Briakinumab for the Treatment of Plaque Psoriasis

Targeting the Interleukin-12/23 Cytokine Family in the Treatment of Psoriatic Disease

(2015) Neil H. Shear et al.   JOURNAL OF CUTANEOUS MEDICINE AND SURGERY

New Interleukin-23 Pathway Inhibitors in Dermatology

(2011) Marta Kurzeja et al.   AMERICAN JOURNAL OF CLINICAL DERMATOLOGY

Efficacy and safety results from a phase III, randomized controlled trial comparing the safety and efficacy of briakinumab with etanercept and placebo in patients with moderate to severe chronic plaque psoriasis

(2011) B.E. Strober et al.   BRITISH JOURNAL OF DERMATOLOGY

Efficacy and safety of briakinumab vs. etanercept and placebo in patients with moderate to severe chronic plaque psoriasis

(2011) A.B. Gottlieb et al.   BRITISH JOURNAL OF DERMATOLOGY

Current status and new developments in the treatment of psoriasis and psoriatic arthritis with biological agents

(2010) Wolfgang Weger   BRITISH JOURNAL OF PHARMACOLOGY

Efficacy and safety of ABT-874, a monoclonal anti–interleukin 12/23 antibody, for the treatment of chronic plaque psoriasis: 36-week observation/retreatment and 60-week open-label extension phases of a randomized phase II trial

(2010) Alexa B. Kimball et al.   JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY

Anti-p40 Antibodies Ustekinumab and Briakinumab: Blockade of Interleukin-12 and Interleukin-23 in the Treatment of Psoriasis

(2010) Mona Gandhi et al.   SEMINARS IN CUTANEOUS MEDICINE AND SURGERY

Ustekinumab: Treatment of Adult Moderate-to-Severe Chronic Plaque Psoriasis

(2009) James V Scanlon et al.   ANNALS OF PHARMACOTHERAPY

Cytokine gene-mediated immunotherapy: Current status and future perspectives

(2009) Masahisa Jinushi et al.   CANCER SCIENCE

Novel cytokine-targeted therapies and intestinal inflammation

(2009) Maximilian J Waldner et al.   CURRENT OPINION IN PHARMACOLOGY

Briakinumab

(2009) Xinaida Taligare Lima et al.   EXPERT OPINION ON BIOLOGICAL THERAPY

Regulation of interleukin-12/interleukin-23 production and the T-helper 17 response in humans

(2009) Lyudmila Lyakh et al.   IMMUNOLOGICAL REVIEWS

New insights into the pathogenesis and genetics of psoriatic arthritis

(2009) Kristine E Nograles et al.   Nature clinical practice. Rheumatology

Safety and Efficacy of ABT-874, a Fully Human Interleukin 12/23 Monoclonal Antibody, in the Treatment of Moderate to Severe Chronic Plaque Psoriasis

(2008) Alexa B. Kimball   ARCHIVES OF DERMATOLOGY